Hantle-ntle ho hola ka eng 14% selemo, le hore na 'maraka oo o hlalosoa joang?
Lits'ebeletso tsa peptide bakeng sa phallo ea tšebetso ea anti-domain e le 'ngoe li kena kae lenaneong la ho sibolla?
Litšebeletso tsa Peptide bakeng sa phallo ea tšebetso ea antibody e le 'ngoe li kena ka lintlha tse hlano, ’me e ’ngoe le e ’ngoe e ja litholoana tsa sethala ka pel’a sona. The scaffold ka boeona e hlalosoa hantle: Tlhaloso ea Muyldermans ea sebaka sa VHH e hlalosa ketane ea H ea li-antibodies tsena tsa homodimeric e nang le sebaka se le seng sa antigen-binding., ea VHH, le libaka tse peli tsa kamehla, ka ho nkeloa ka ho khannoa ke boholo, kamano, tse khethehileng, botsitso le litšenyehelo tsa tlhahiso (Muyldermans, Annu Rev Biochem, 2013). The 1993 ho sibolloa ha li-antibodies tsa camelid tse nang le ketane e boima feela ho bontšitse hore limolek'hule tsena ke li-dimers tse boima tse se nang liketane tse bobebe empa li na le pokello e kholo ea li-antigen tse tlamang., mme li-IgG tsa likamele tse boima ha li na CH1 (Hamers-Casterman et al., Tlhaho, 1993).
Karohano ea mosebetsi e otlolohile: sdAb e fana ka scaffold e tlamang, 'me peptide e fana ka tatellano e hlalositsoeng eo u ka e hlalosang masala ka masalela, fetola sebakeng se khethiloeng, le sebopeho sa HPLC le MS. Li-peptide ha li nke sebaka sa scaffold, 'me meeli ke ea sebele. Li-peptide li bonts'a kamano e tlase le halofo ea bophelo bo khuts'oane 'meleng ho feta li-antibodies, ka ho tsoa ka potlako le ho ba kotsing ea ho senyeha ha protease-mediated e le mefokolo e emeng. (Exp Mol Med, 2023). Seo ba fanang ka sona e le phapanyetsano ke ho kenella ha lisele tse tebileng, ho kenya letsoho ka tsela e sebetsang hantle, immunogenicity e tlase le phetoho e bonolo ea lik'hemik'hale, le ho feta 80 Peptide therapeutics e 'marakeng.
Khoebo ke ka lebaka leo lehlakore la peptide e leng karolo ea lenaneo la ho sibolla ho hang. Peptide ea 15-mer epitope e nang le N-terminal cysteine bakeng sa conjugation e tsamaisang thepa ke sesebelisoa seo u ka se laelang., netefatsa le ho hlophisa bocha; scaffold ke bioloji eo u tlamehang ho e hlalosa le ho e khetholla. Mehato e mehlano e ka tlase e nka peptide e le e ka hlahisoang le sdAb joalo ka 'mali.
U etsa joang le ho hlakisa 'mapa oa li-epitope le ho laola li-peptide?
'Mapa oa Epitope o nang le li-peptide tsa maiketsetso o qala ho tsoa ho moralo oa lithaele 'me o fella lethathamong la masimo leo u le fang morekisi.. Sekoahelo sa mantlha sa epitope ea peptide se ile sa kopanya makholo a li-peptide ka nako e le 'ngoe holim'a litšehetso tse tiileng tsa bohloeki bo lekaneng ho arabela ELISA., e fumane karolo ea immunogenic ea kokoana-hloko ea lefu la leoto le molomo e ja setsi sa protheine ea mofuta oa O1 ho isa ho li-amino acid 146-152 ka qeto ea li-amino acid tse supileng., joale synthesized sete e feletseng e nkelang sebaka sa tsohle 20 li-amino acid sebakeng se seng le se seng ka har'a epitope (Geysen, Lehapu & Barteling, PNAS, 1984). Sete e ncha e ile ea fumana masala a leucine maemong 148 le 151 E bohlokoa bakeng sa karabelo ea antisera e phahamisitsoeng khahlano le kokoana-hloko e sa fetoheng.
Sekena sa alanine se hlalositseng li-hotspots tse tlamang se sebelisitse mohopolo o fapaneng oa phetoho bothateng bo fapaneng. Cunningham le Wells li hlahisitsoe 62 Phetoho e le 'ngoe ea alanine sebakeng se seng le se seng ka har'a likarolo tse tharo tse sa khaotseng tsa hormone ea ho hōla ha motho (mesaletsa 2-19, 54–74 le 167–191) mme a fumana sehlopha sa diketane tse kgolo tse ka mahlakoreng tse leshome le metso e mmedi tseo e nngwe le e nngwe e theosetsang kamano e tlamang ho feta hane ha e fetolwa., mmoho le masalla a le mong, Glu174, whose mutation to alanine increased receptor affinity by more than a factor of four (Cunningham & Wells, Saense, 1989). The cross-source finding is the one that changes a specification: a single substitution series yields both loss-of-binding and gain-of-binding hits, so a spec built only around “essential residues” misses the second class entirely.
Peptide Bakeng sa Keletso The field list a buyer writes for an epitope-mapping or control peptide: tatelano e tletseng, N- le boemo ba C-terminus, sebaka sa phetoho le k'hemistri, tlhoeko kereiti, foromo ea counterion, nomoro ea lotho, and the method ID behind the purity and identity values.
Two limitations belong inside this stage rather than in a closing caveat. Substitutions can alter peptide structure or presentation, and alanine is not ideal at every position, so a scan result is evidence about a peptide, not a proof about the folded antigen. 'Me potso ea linear-khahlanong le-conformational ha e rarolloe ke mehloli e baloang mona: li-peptide tse melang tse holimo li ka hlahisa li-epitopes tse tsoelang pele, empa hore na epitope e fanoeng e sa khaotseng e tla fana ka pontšo leha e le efe ke potso eo bopaki ba hona joale bo sa e arabeng, le lenaneo le hlokang karabo eo le lokela ho le nka e le ntho e bulehileng ho e-na le tlhaloso.
Ke lifomate life tsa peptide tse etsang hore tlhahlobo e sebetse, le kamoo u ka pakang ho tšoaneleha ha tlhahlobo?
Qeto ea sebopeho ke ho nka k'hemistri le boemo ba bohloeki, mme bobedi bo lokela ho kgethwa mmoho. Ho ts'oaroa ha Biotin-streptavidin ka letsoho la spacer ho etsa hore motho a se ke a sisinyeha lipoleiting tsa ELISA., Li-chips tsa SPR le li-sensor tsa BLI; li-spacers tsa aminohexanoic acid li khuts'oane ebile li thata ha li-spacers tsa PEG li le telele ebile lia tenyetseha, 'me ka bobeli li hole peptide ho tloha sebakeng sa sensor ho fokotsa tšitiso ea steric ho tloha lera la streptavidin., e lumellang masole a 'mele ho tlama li-epitope tsa tsona ka kinetics tse tšoanang le tse bonoang tharollong (Li-Peptide tsa Pōpo, kgutlisitsoe 2026). Streptavidin–biotin ha e khone ho etsolloa tlas'a maemo a tloaelehileng, e leng sona se etsang hore tshekamelo e ikatise le bokahodimo bo laoleheng.
Limaraka tse hatisitsoeng tsa barekisi ke lintlha tsa pele tseo ho ka buisanoang ka tsona. Khetha mekhoa ea ho amoheloa ho tsoa ho kutloisiso ea tlhahlobo, ts'ebetso ea litšila le litlhoko tsa bongata. Tlhahlobo ea boleng ha e sireletsehe ka bo eona ho tsoa litšila tse sebetsang ka ho sebelisa 85% mophato.
Tlaleho ea boitsebiso, bohloeki ba sebaka sa chromatographic le litaba tsa peptide ka thoko, ka mokhoa le motheo oa e 'ngoe le e 'ngoe. Intact MS e tšehetsa boitsebiso empa ha bo joalo, ka boyona, tlhahlobo e netefalitsoeng ea bohloeki bo akaretsang. Likahare tsa Net peptide li ka kenyelletsa mefuta e amanang le peptide; target-peptide content e hloka tekanyo ea eona e hlalositsoeng.
U khetha joang k'hemistri ea conjugation ntle le ho senya tlamo?
Conjugation chemistry e khethoa ke sehlopha se sebetsang seo u ikemiselitseng ho se fetola, le maemo a tloaelehileng a karabelo ea bioconjugation a qobella likhetho tse peli. Khemistri ea NHS-ester e sebetsana le li-amine tsa mantlha ho pH 7.2-8.5 ho feta 30 metsotso ho 4 lihora ka mocheso oa kamore kapa 4 °C ho theha maqhama a tsitsitseng a amide, ho lokolla N-hydroxysuccinimide; Tris le li-buffers tse ling tsa mantlha tsa amine lia qothisana lehlokoa 'me ha li lumellane, 'me halofo ea bophelo ba hydrolysis ke lihora tse 4-5 ho pH 7.0 le 0 °C empa e oela hoo e ka bang 10 metsotso ho pH 8.6 le 4 °C (Thermo Fisher Scientific, kgutlisitsoe 2026). Li-esters tsa Sulfo-NHS li eketsa sehlopha sa sulfonate se eketsang ho qhibiliha ha metsi le ho thibela ho kenella ha membrane..
Khemistri ea Maleimide ke mokhoa o mong ha peptide e na le sulfhydryl ea mahala. Maleimide-activated crosslinkers le li-label reagents li sebetsana ka ho khetheha le lihlopha tsa sulfhydryl pH 6.5-7.5 ho theha likhokahano tse tsitsitseng tsa thioether., le ho feta pH 8.5 karabelo e rata li-amine tsa mantlha ha maleimide hydrolysis ho non-reactive maleamic acid e potlakisa (Thermo Fisher Scientific, kgutlisitsoe 2026). Sulfo-SMCC ke heterobifunctional crosslinker e nang le amine-reactive sulfo-NHS ester le maleimide ea sulfhydryl-reactive holim'a cyclohexane spacer. (MW 436.37, letsoho la spacer 8.3 Oh), eleng sona se kgontshang tatellano ya mehato e mmedi.
Enzymatic Peptide Synthesis Bakeng sa sequential NHS-ester/maleimide chemistry, ntlafatsa sethala ka seng 'me u sebelise phapanyetsano e nepahetseng ea buffer kapa tlhoekiso lipakeng tsa methati. Ha ho hlokahale ho tsamaisa karabelo ka bobeli fensetereng e le 'ngoe e moqotetsane ea pH. Hlahloba hydrolysis, khetho ea sebaka le botsitso ba conjugate.
Khetho ea ho ngola e fetola joang seo u se lekanyang?
Khetho ea ho ngola e fetola tekanyo hobane leibole ke karolo ea reagent, e seng palo e tlatsitsoeng ka mor'a moo. Bakeng sa likaroloana tsa FRET peptide, kutlo e khethoa haholo-holo ke sebaka se pakeng tsa fluorophore le quencher, e lokelang ho ba boemong ba 10–100 Å, le ka boholo ba ho kopana pakeng tsa sebono sa ho monyela ha quencher le khanya ea fluorophore's emission spectrum.; bakeng sa li-enzyme tse thehiloeng ho FRET hangata ho molemo ho beha para ho N- le C-termini ho fapana le liketane tsa mahlakore a amino-acid, hobane seo se qoba ho fetola tatellano ea peptide ea matsoalloa (Merck Millipore, 2026). Ho khetha C-terminal label ha ho hlokahala N-terminus bakeng sa ts'ebetso ea baeloji.
Mekhahlelo e lekantsoeng e tlamang e na le kotsi e ts'oanang. The fluorescence ligand e lokela ho raloa e le hore sehokelo sa fluorophore ka sehokelo se loketseng se se ke sa ama kamano e tlamang le khetho ea ligand ea motsoali., le tekanyo ea ho ngola, palo ea masalla a ngotsoeng ka molek'hule, ke ntlha ea bohlokoa ho boleng ba tlhahlobo e amang Peptide P ho ikatisa hoa litekanyo (PMC10788520, 2023). Tlhahlobo e ts'oanang e hlokomela hore ho fumaneha ha masala a amohelehang ho covalent labeling ntle le ho fetola tšebelisano kapa botsitso ba protheine ke moeli., e leng tšitiso e etsang qeto ya hore na leibole le ka ya kae.
Liphetho tse sebetsang ke hore reagent ea peptide e ngotsoeng e hloka tekanyo ea eona ea ho ngolisoa ka mokhoa o hlakileng., ha ho nahanoe. Tokisetso e nang le palo e fapaneng ea lileibole ka molek'hule e hlahisa lets'oao le feto-fetohang, 'me tlhahlobo ea bongata e hahiloeng holim'a eona e ke ke ea ikatisa. Moo lenaneo le hlokang mofuta o ngotsoeng le o sa ngolisoang oa tatellano e tšoanang, tse peli ke li-reagents tse arohaneng tse nang le mekhoa e fapaneng ea ho amohela, 'me boemo ba ho ngola ke qeto ea moralo e entsoeng pele peptide e laeloa. Mofani oa Peptide
Sephutheloana sa analytical le QC se tlameha ho ba le eng bakeng sa reagent ea peptide ts'ebetsong ena ea mosebetsi?
Sephutheloana sa QC ke tlhaloso ka kutloisiso ea ICH Q6B: liteko, mekhoa ea ho hlahloba le mekhoa ea ho amohela, beha le ho lokafatsa bakeng sa sehlahisoa. ICH Q6B e fana ka tataiso mabapi le melao-motheo e akaretsang bakeng sa ho beha le ho lokafatsa sete e tšoanang ea litlhaloso tsa machaba bakeng sa lihlahisoa tsa biotechnology le tsa baeloji ho tšehetsa lits'ebetso tse ncha tsa papatso. (US FDA / Ke Q6B, 1999). E beha melao-motheo, eseng meeli ea linomoro, kahoo lipalo li tlameha ho tsoa ho mokhoa le ts'ebeliso.
Hlalosa endotoxin ho tsoa ho ts'ebeliso e reriloeng le kutloisiso ea tlhahlobo. Moralo oa parenteral K/M ha se moeli oa kamehla bakeng sa reagent e tlamang ka in vitro. Kenyelletsa tatellano, termini, sebaka sa phetoho, label stoichiometry, motheo oa litaba, li-ID tsa mekhoa le traceability ea lotho ho kopo.
Litaba tsa Hydrophobic li ka tšoaea kotsi ea ho bokellana, empa ha ho molao oa palo ea masalla o tiisang hore o kopanya kapa o qhibiliha. Liphello tsa Counterion li ipapisitse le boemo ba 'nete le mahloriso a tlhahlobo; lekanya le ho lokafatsa moeli o loketseng ho e-na le ho hloka sepheo se le seng sa phapanyetsano ea TFA ea bokahohle.
Ke neng moo peptide reagent e leng khetho e fosahetseng?
Peptide reagent ke khetho e fosahetseng ha potso e hloka antigen e mennweng kapa binder ea nako e telele.. Li-peptide li bonts'a kamano e tlase le halofo ea bophelo bo khuts'oane ho feta li-antibodies, ka ho tsoa ka potlako le ho ba kotsing ea protease joalo ka mefokolo e emeng, 'me likhetho tsa ho atolosa halofo ea bophelo ke Fc fusion, PEGylation, ho kopanya mafura-asiti le ho tlama ha albumin (Exp Fmoc Peptide Mol Med, 2023). Tlhahlobo e fapaneng e tlaleha halofo ea bophelo ba GLP-2 e atolositsoeng ho tloha 7 metsotso ho isa ho lihora tse ka bang 2-3 ka phetoho e le 'ngoe ea N-terminal, e leng sekala se molemo sa hore na phetoho e ka tsamaisa palo hole hakae (Signal Transduct Target Ther, 2022). Haeba tlhahlobo e hloka reagent e phelang ka serum ka matsatsi, peptide ke reagent e fosahetseng.
Molao oa qeto o latelang ho tloha methating e mehlano: Odara reagent ea peptide ha e tlisoang e le tatellano e hlalositsoeng, o ka hlakisa masala ka masala., fetola sebakeng se khethiloeng, le ho netefatsa ka HPLC le MS, le ha teko e mamella kamano le halofo ea bophelo sebopeho se fanang ka sona. Laela scaffold ha potso e hloka antigen e mennoeng, motlami wa nako e telele, kapa tshebetso e sebetsang. Moo lenaneo le hlokang ka bobeli, tse peli ke lintlha tse arohaneng tsa line tse nang le litlhaloso tse fapaneng, 'me tlhahlobo ea litlhaloso tsa peptide ke mohato o thibelang bobeli hore bo se ke ba kopana. Tlhahlobo e hlakileng le setsebi sa tekheniki ke mohato o latelang oa boitlamo ba mahareng bakeng sa lenaneo le nang le lenane la masimo empa eseng litekanyetso tsa ho amoheloa.. Hepcidin Synthesis
Lipotso Tse Botsoang Khafetsa
Likahare tsa peptide tsa net li bolela eng ho setifikeiti sa tlhahlobo?
Net peptide content ke karolo e lekantsoeng ea peptide ea thepa e fanoeng tlas'a mokhoa o boletsoeng le motheo; ha ho hlokahale hore e bolele peptide e reretsoeng feela. Sebelisa sephetho sa lotho ea sebele 'me u be le akhaonto ea mefuta e amanang le li-peptide moo ho hlokahalang. Se ke oa nahana hore lotho e 'ngoe le e' ngoe e na le 60-80% peptide kapa u sebelise tokiso ea bobeli ea bohloeki tekong e seng e tobane le sepheo..
Na peptide ea biotinylated e ka ea ka kotloloho ho chip ea streptavidin SPR?
Peptide ea biotinylated e ka 'na ea tšoaroa holim'a streptavidin haeba li-geometry le li-assay controls li loketse.. Ho tlosa analyte e tlanngoeng hore e sebelisoe hape ho fapane le ho tlosa ligand tse hapiloeng tsa biotinylated. Hore na ho tsosolosoa hoa khoneha ho itšetlehile ka tšebelisano le botsitso ba holim'a metsi; ho ts'oaroa ha ligand e sa fetoheng ha ho thibele ho nchafatsa analyte ka bohona.
DAR e lekantsoe joang, le hore na ke lokela ho hlalosa mofuta ofe?
DAR e lekantsoe ke LC-MS ka mekhahlelo e meraro, mme mohato ka mong o araba potso e fapaneng. Boima bo sa fetoheng ka mor'a deglycosylation bo fana ka karolelano ea karolelano ho baahi bohle; tlhahlobo ea subunit ka mor'a tshilo ea IdeS kapa phokotso e rarolla tlatsetso ea ketane e boima le e bobebe; le 'mapa oa peptide ka tšilo ea trypsin kapa chymotrypsin e lateloang ke LC-MS e fumana libaka tseo ha e le hantle li tsamaisang conjugate. (Novor e potlakileng, 2025). Hlalosa fensetere e patisaneng ho fapana le nomoro e le 'ngoe, 'me u tšoare DAR 3–4 optimum e qotsitsoeng hohle ka hloko: e tsoa ho antibody-drug conjugate work, eseng ho tsoa ho li-conjugates tsa peptide (PMC9959917, 2023). Khokahano e laoloang ho ea ho DAR 2 e tlalehiloe le 99.76% bohloeki ba monomer le ts'ebetso e bolokiloeng ea in vitro (BioDuro, 2026).
Na counterion ea TFA e na le taba bakeng sa tlhahlobo e thehiloeng ho lisele?
E ka khona, 'me phello e bonolo ho fosa hobane ha e hlahe ka mokhoa o hloekileng. Trifluoroacetate ke khanyetso e siiloeng morao ke tlhoekiso e tloaelehileng ea reverse-phase, 'me ke cytotoxic libakeng tseo tlhahlobo ea lisele e ka li fihlelang, kahoo peptide e sebetsang ka mokhoa o phethahetseng tekong e tlamang e ka hatella lisele tseo e reretsoeng ho li hlahloba.. Haeba 'malo oa hau o kenyelletsa lisele tse phelang, kopa hore counterion e boleloe setifikeiti sa tlhahlobo mme o nahane ka phapanyetsano ea letsoai ho acetate bakeng sa aliquot e sebetsang. Tlhokomeliso e tšoanang e sebetsa ho mokelikeli ofe kapa ofe o setseng o tsoang ho cleavage..
E ka nkela VHH sebaka sa peptide tekong e tlamang?
Ka linako tse ling peptide e ka sebetsa mosebetsi o hlokahalang, empa ho nkela VHH sebaka ho hloka netefatso bakeng sa kamano, tse khethehileng, geometry le botsitso. Leha e le scaffold e ke keng ea nkela e 'ngoe sebaka.
